Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHA:600329)
China flag China · Delayed Price · Currency is CNY
41.45
-0.50 (-1.19%)
May 21, 2026, 3:00 PM CST

SHA:600329 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
28,37730,77820,69922,12118,24619,473
Market Cap Growth
39.92%48.69%-6.43%21.24%-6.30%73.88%
Enterprise Value
26,66729,07920,51920,90316,17817,504
Last Close Price
41.9543.2328.0929.5124.9826.35
PE Ratio
14.8314.449.2922.4221.1725.32
Forward PE
28.7324.6618.4020.0422.8722.87
PS Ratio
5.706.262.832.692.212.82
PB Ratio
3.774.342.643.332.792.99
P/TBV Ratio
3.924.522.753.562.963.16
P/FCF Ratio
68.1089.8825.6540.4032.0528.00
P/OCF Ratio
53.7766.7522.3932.1326.9422.85
EV/Sales Ratio
5.365.912.812.541.962.53
EV/EBITDA Ratio
23.5628.3322.9122.0620.5824.96
EV/EBIT Ratio
26.0531.6826.5125.4624.1029.82
EV/FCF Ratio
64.0084.9225.4338.1728.4225.17
Debt / Equity Ratio
0.010.010.010.050.040.01
Debt / EBITDA Ratio
0.050.070.040.360.340.06
Debt / FCF Ratio
0.140.220.050.620.470.06
Net Debt / Equity Ratio
-0.23-0.60-0.50-0.28-0.40-0.36
Net Debt / EBITDA Ratio
-1.51-4.15-4.36-1.95-3.38-3.35
Net Debt / FCF Ratio
-4.10-12.43-4.84-3.37-4.66-3.38
Asset Turnover
0.460.440.700.810.860.80
Inventory Turnover
1.111.092.673.093.382.76
Quick Ratio
1.261.311.871.511.711.81
Current Ratio
2.161.592.352.032.172.64
Return on Equity (ROE)
27.46%28.24%30.56%14.68%13.37%12.63%
Return on Assets (ROA)
5.92%5.11%4.61%5.03%4.37%4.23%
Return on Invested Capital (ROIC)
20.09%22.95%15.21%16.70%14.84%12.96%
Return on Capital Employed (ROCE)
13.50%12.80%9.70%11.70%9.80%8.90%
Earnings Yield
7.68%6.92%10.77%4.46%4.72%3.95%
FCF Yield
1.47%1.11%3.90%2.48%3.12%3.57%
Dividend Yield
11.16%11.08%4.56%4.34%4.48%1.90%
Payout Ratio
131.09%46.05%45.33%88.91%44.96%30.17%
Buyback Yield / Dilution
-0.30%0.27%-0.07%0.71%-0.94%0.04%
Total Shareholder Return
10.50%11.35%4.49%5.05%3.54%1.93%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.